SCHEMBL774065

SCHEMBL774065

N#Cc1ccc2c(c1)CN(CCC(=O)O)CC2

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DRD2 P14416 14/20 0.64
DRD3 P35462 13/20 0.64
DRD4 P21917 2/20 0.59
OPRM1 P35372 2/20 0.59
HTR1A P08908 1/20 0.54
HTR2A P28223 1/20 0.54
SLC6A4 P31645 1/20 0.54
HTR7 P34969 1/20 0.54
HRH1 P35367 1/20 0.54
HTR2B P41595 1/20 0.54
HTR1D P28221 5/20 0.51
HTR1B P28222 5/20 0.51
S1PR1 P21453 2/20 0.49
AKR1C3 P42330 1/20 0.47
PRMT5 O14744 1/20 0.47
WDR77 Q9BQA1 1/20 0.47
CYP2D6 P10635 2/20 0.47
S1PR3 Q99500 1/20 0.46
KDM4E B2RXH2 1/20 0.45
ALOX15 P16050 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3466653 0.86 DRD2 (0.60) DRD2DRD3DRD4OPRM1HTR1A
SCHEMBL773073 0.82 DRD2 (0.64) DRD2DRD3DRD4OPRM1HTR1A
SCHEMBL15756197 0.80 KMT2A (0.55) DRD2DRD3HTR1AHTR2ASLC6A4
SCHEMBL3348927 0.78 DRD2 (1.00) DRD2DRD3DRD4OPRM1HTR1A
SCHEMBL81130 0.77 DRD2 (0.74) DRD2DRD3DRD4OPRM1HTR1A
SCHEMBL12663322 0.77 DRD2 (0.66) DRD2DRD3DRD4OPRM1HTR1A
SCHEMBL7844061 0.77 DRD2 (0.74) DRD2DRD3DRD4OPRM1HTR1A
SCHEMBL3477555 0.77 HDAC3 (0.70) DRD2DRD3HTR1AHTR2ASLC6A4
SCHEMBL798065 0.76 HTR5A (0.47) DRD2DRD3DRD4OPRM1HTR1A
SCHEMBL15942966 0.76 S1PR1 (0.47) DRD2DRD3HTR1AHTR2ASLC6A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2440554-B1 PYRAZOLE OXADIAZOLE DERIVATIVES AS S1P1 AGONISTS MERCK SERONO SA (CH) 2016-10-05 EP disclosed
US-8802663-B2 Pyrazole oxadiazole derivatives as S1P1 agonists MERCK SERONO SA (CH) 2014-08-12 US disclosed
US-20120071460-A1 PYRAZOLE OXADIAZOLE DERIVATIVES AS S1P1 AGONISTS MERCK SERONO SA (CH) 2012-03-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120071460-A1 PYRAZOLE OXADIAZOLE DERIVATIVES AS S1P1 AGONISTS S1PR1, S1PR3, S1PR2 DRD2 553/4885DRD3 285/4885DRD4 1375/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.